The complaint alleges a pattern of deception spanning from January 29, 2025, to March 4, 2026. According to the court filings, SES AI allegedly overstated its growth prospects by inflating the potential results of deals with companies lacking substantial operations. Furthermore, the firm is accused of manufacturing revenue through circular transactions involving the purchase of Molecular Universe services.

Beyond these allegations, the lawsuit claims that SES AI failed to disclose material logistics constraints during the fourth quarter of 2025. These operational hurdles, which were withheld from the public, reportedly crippled the company’s revenue projections and cast doubt on its 2026 growth outlook. Investors interested in the action can contact attorney Charles Linehan in Los Angeles to discuss their legal rights or participation in the class.